Home » Authors » Nuala Moran

Articles by Nuala Moran

MVM Raising £40M To Invest In Young U.S., UK Companies

Feb. 28, 2001

Xenova, Cantab Merging Via All-Stock Deal Valued At £124

Feb. 21, 2001

Cyclacel Moves Oral CDK Inhibitor Into Human Trials

Feb. 21, 2001

Pharming Completes Study, Enters Deal With AM-Pharma

Feb. 21, 2001

Cyclacel Moves Oral CDK Inhibitor Into Human Trials

Feb. 21, 2001

Xenova, Cantab Merging Via All-Stock Deal Valued At £124

Feb. 21, 2001

Pharming Completes Study, Enters Deal With AM-Pharma

Feb. 21, 2001

HUPO Formed To Capitalize On Genome, Advance Proteomics

Feb. 20, 2001

HUPO Formed To Capitalize On Genome, Advance Proteomics

Feb. 20, 2001

KS Biomedix Moves Lead Drug Into Phase IIb, Eyes Pivotal Trial

Feb. 14, 2001

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026